Jul 30, 2013 (Morning Edition) — The world's largest drugmaker says it's planning on dividing its business into separate units for brand-name drugs and generics. The company's generics have a far lower profit margin than drugs protected by patents.
This text will be replaced
Missing some content? Check the source: NPR
Copyright(c) 2013, NPR